Amy Simon - 31 Jan 2024 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
Chief Medical Officer
Signature
By: /s/ Christine Bellon, Attorney-in-fact
Issuer symbol
BEAM
Transactions as of
31 Jan 2024
Transactions value $
$1,342,000
Form type
4
Filing time
02 Feb 2024, 16:05:21 UTC
Previous filing
01 Nov 2023
Next filing
02 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Award $1.34M +55K $24.40 55K 31 Jan 2024 Common Stock 55K $24.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with Beam Therapeutics Inc. through each vesting date.